DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,086,723 | $85,910,000 | 25.70% |
SV Health Investors, LLC | 449,951 | $18,525,000 | 15.54% |
Redmile Group, LLC | 5,116,263 | $210,637,000 | 5.90% |
Eversept Partners, LP | 414,081 | $17,047,715 | 4.24% |
Sunesis Advisors, LLC | 96,299 | $3,965,000 | 3.99% |
Avoro Capital Advisors LLC | 2,000,000 | $82,340,000 | 2.78% |
Opaleye Management Inc. | 222,000 | $9,140,000 | 2.42% |
SECTORAL ASSET MANAGEMENT INC | 204,059 | $8,401,000 | 1.61% |
Artal Group S.A. | 800,000 | $32,936,000 | 1.39% |
Atika Capital Management LLC | 141,000 | $5,805,000 | 1.11% |